Related Experiment Video
Updated: Sep 16, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Targeting Programmed Cell Death as an Innovative Strategy Against Atherosclerosis: Potential of Natural Compound
Jilin Fan1, Tingting Zhu1, Xiaoling Tian1
1Binzhou Medical University Hospital, Binzhou, Shandong, China.
Abstract:
Atherosclerosis (AS) is the primary pathological basis of various cardiovascular diseases. Its pathogenesis involves multiple processes, including inflammatory responses, lipid metabolism disorders, and cell death. Recently, programmed cell death (PCD), comprising apoptosis, autophagy, pyroptosis, necroptosis, and ferroptosis, has attracted considerable attention as a potential therapeutic target in AS progression. Furthermore, natural compounds with anti-atherosclerotic properties derived from plants have gained wide interest. These natural products regulate PCD through various mechanisms and demonstrate significant potential for the prevention and treatment of AS. Therefore, this review summarizes the molecular mechanisms of critical PCD pathways involved in AS and discusses the latest findings on natural products, such as flavonoids, polyphenols, saponins, and alkaloids that target PCD to alleviate AS. Based on these findings, this review highlights the importance of natural compounds targeting PCD as a therapeutic strategy against AS, providing novel theoretical insights and translational directions to promote the development of precise anti-atherosclerotic therapies derived from natural products.
Insights
Natural compounds can target programmed cell death (PCD) pathways to combat atherosclerosis (AS). This review explores how plant-derived molecules like flavonoids and polyphenols offer therapeutic potential for AS by modulating cell death mechanisms.
Area of Science:
- Biomedical Science
- Pharmacology
- Cardiovascular Research
Background:
- Atherosclerosis (AS) is a major cause of cardiovascular disease, driven by inflammation, lipid disorders, and cell death.
- Programmed cell death (PCD), including apoptosis, autophagy, pyroptosis, necroptosis, and ferroptosis, is increasingly recognized as a key factor in AS progression.
Purpose of the Study:
- To review the molecular mechanisms of critical PCD pathways in AS.
- To discuss the therapeutic potential of natural compounds targeting PCD for AS treatment and prevention.
Main Methods:
- Literature review of molecular mechanisms of PCD in AS.
- Analysis of natural products (flavonoids, polyphenols, saponins, alkaloids) and their effects on PCD pathways in AS.
Main Results:
- PCD pathways are integral to AS pathogenesis.
- Natural compounds modulate various PCD pathways to alleviate AS.
- Specific natural product classes show promise in targeting PCD for AS therapy.
Conclusions:
- Targeting PCD with natural compounds represents a promising therapeutic strategy for AS.
- Further research into these natural products can provide insights for developing precise anti-atherosclerotic therapies.
Related Concept Videos
Atherosclerosis III: Management
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Inflammation
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Apoptosis

